Hemispherx Biopharma, Inc. 32,000,000 Shares of Common Stock Par Value $0.001 per Share Equity Distribution AgreementHemispherx Biopharma Inc • May 28th, 2010 • Biological products, (no disgnostic substances) • New York
Hemispherx Biopharma, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, up to 32,000,000 shares (the “Shares”) of Common Stock, $0.001 par value per share, of the Company (the “Common Stock”) on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
